Xiang Li

Xiang Li

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in Small Methods
Verified
Journal Article
Closed access
PDF file
HLHuimin Lin
Huimin Lin
SSShanwei Shi
Shanwei Shi
XLXinyue Lan
Xinyue Lan
XQXiaolong Quan
Xiaolong Quan
QXQinqin Xu
Qinqin Xu
MYMeng Yu
Meng Yu

1 August 2016 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
XLXiang Li
Xiang Li
TCTao Chen
Tao Chen
JHJing Hu
Jing Hu
SLShujun Li
Shujun Li
QZQin Zou
Qin Zou
JLJihua Li
Jihua Li

14 March 2015 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
XLXiang Li
Xiang Li
YLYubao Li
Yubao Li
YZYi Zuo
Yi Zuo
DQDan Qu
Dan Qu
YLYiming Liu
Yiming Liu
JLJihua Li
Jihua Li

7 April 2025 in ACS Nano
Verified
Journal Article
Open access
SYShan Yu
Shan Yu
JLJingyuan Li
Jingyuan Li
JZJie Zhang
Jie Zhang
GZGuozhong Zeng
Guozhong Zeng
BZBin Zeng
Bin Zeng
YLYujie Liang
Yujie Liang
Head and neck squamous cell carcinoma (HNSCC) frequently develops resistance to immune checkpoint blockade (ICB) therapy, resulting from an immune-excluded microenvironment. Immunogenic cell death (ICD) can increase tumor immunogenicity and further augment immune-cell infiltration by releasing immunogenic molecules. Hence, inducing ICD within tumors might be a promising strategy to restore antitumor immunity and sensitize HNSCC to ICB. Herein, we developed shikonin (SHK)-loaded, CGKRK-modified lipid nanoparticles (C-SNPs) and demonstrated that C-SNPs could enrich in tumor cells and induce necroptosis in vitro and in vivo. Transcriptomic profiling revealed that C-SNPs suppressed tumor-cell mismatch repair, which later activated the cGAS-mediated IFN response and further increased the expression of PD-L1. Combining C-SNPs with an anti-PD-1 antibody increased the infiltration of DCs and CD8+ T cells, yet the response was limited. Modifying C-SNPs with Mn2+ (C-SMNPs) enhanced the activation of cGAS-STING signaling and further boosted the maturation of DCs and the differentiation of cytotoxic T cells within ICB-treated tumors. Importantly, compared to C-SNPs, the combination of C-SMNPs with ICB resulted in more sustained tumor suppression in vivo. Together, we developed a versatile nanoparticle that delivered SHK and Mn2+ which sensitized HNSCC to ICB by disrupting tumor-cell mismatch repair and boosting the cGAS-STING-mediated IFN response. This nanosized ICD inducer-based strategy holds therapeutic potential in synergizing with anti-PD-1 immunotherapy to enhance treatment efficacy in HNSCC.

1 October 2013 in Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
XLXiang Li
Xiang Li
YHYuchun Hsu
Yuchun Hsu
JHJing Hu
Jing Hu
AKAshish Khadka
Ashish Khadka
TCTao Chen
Tao Chen
JLJihua Li
Jihua Li

15 July 2022 in Polymers
Verified
Journal Article
Open access
PDF file
ZLZhengshi Li
Zhengshi Li
HLHuimin Lin
Huimin Lin
SSShanwei Shi
Shanwei Shi
KSKai Su
Kai Su
GZGuangsen Zheng
Guangsen Zheng
GLGuiqing Liao
Guiqing Liao
Bone healing is a complex process that requires the participation of cells and bioactive factors. Stromal derived factor-1 α (SDF-1α) and magnesium ions (Mg2+) both are significant bioactive factors for cell recruitment and osteogenesis during bone regeneration. Thus, a bifunctional hydrogel containing a sequential delivery system is fabricated to improve osteogenesis. During sequential delivery of the hydrogel, SDF-1α is predominantly released at the early stage of bone mesenchymal stem cells (BMSCs) recruitment, while Mg2+ are constantly delivered at a later stage to improve osteogenic differentiation of recruited cells. In addition, due to the early release of SDF-1α, the hydrogel showed strong BMSCs recruitment and proliferation activity. Mg2+ can not only induce up-regulation of osteogenic gene expression in vitro, but also promote bone tissue and angiogenesis in vivo. Taken together, the injection of xanthan gum-polydopamine crosslinked hydrogel co-loading SDF-1α and Mg2+ (XPMS hydrogel) provides a novel strategy to repair bone defects.